BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23587962)

  • 1. Modulation of PF10_0355 (MSPDBL2) alters Plasmodium falciparum response to antimalarial drugs.
    Van Tyne D; Uboldi AD; Healer J; Cowman AF; Wirth DF
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2937-41. PubMed ID: 23587962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum.
    Van Tyne D; Park DJ; Schaffner SF; Neafsey DE; Angelino E; Cortese JF; Barnes KG; Rosen DM; Lukens AK; Daniels RF; Milner DA; Johnson CA; Shlyakhter I; Grossman SR; Becker JS; Yamins D; Karlsson EK; Ndiaye D; Sarr O; Mboup S; Happi C; Furlotte NA; Eskin E; Kang HM; Hartl DL; Birren BW; Wiegand RC; Lander ES; Wirth DF; Volkman SK; Sabeti PC
    PLoS Genet; 2011 Apr; 7(4):e1001383. PubMed ID: 21533027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
    Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
    PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
    Ochola-Oyier LI; Okombo J; Mwai L; Kiara SM; Pole L; Tetteh KK; Nzila A; Marsh K
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1770-5. PubMed ID: 25534732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
    Sidhu AB; Uhlemann AC; Valderramos SG; Valderramos JC; Krishna S; Fidock DA
    J Infect Dis; 2006 Aug; 194(4):528-35. PubMed ID: 16845638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east Myanmar.
    Gupta B; Xu S; Wang Z; Sun L; Miao J; Cui L; Yang Z
    J Antimicrob Chemother; 2014 Aug; 69(8):2110-7. PubMed ID: 24855124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
    Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
    Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
    Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
    Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Polymorphisms in the Pf
    Gendrot M; Diawara S; Madamet M; Kounta MB; Briolant S; Wade KA; Fall M; Benoit N; Nakoulima A; Amalvict R; Diémé Y; Fall B; Wade B; Diatta B; Pradines B
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
    Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
    PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for linkage of pfmdr1, pfcrt, and pfk13 polymorphisms to lumefantrine and mefloquine susceptibilities in a Plasmodium falciparum cross.
    Windle ST; Lane KD; Gadalla NB; Liu A; Mu J; Caleon RL; Rahman RS; Sá JM; Wellems TE
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():208-217. PubMed ID: 33197753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
    Legrand E; Yrinesi J; Ekala MT; Péneau J; Volney B; Berger F; Bouchier C; Bertani S; Musset L; Meynard JB; Mercereau-Puijalon O
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1382-9. PubMed ID: 22232280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat polymorphisms in the low-complexity regions of Plasmodium falciparum ABC transporters and associations with in vitro antimalarial responses.
    Okombo J; Abdi AI; Kiara SM; Mwai L; Pole L; Sutherland CJ; Nzila A; Ochola-Oyier LI
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6196-204. PubMed ID: 24080667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing Antimalarial Drug Sensitivities in Uganda.
    Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.
    Chavchich M; Gerena L; Peters J; Chen N; Cheng Q; Kyle DE
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2455-64. PubMed ID: 20350946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.
    Okombo J; Kiara SM; Rono J; Mwai L; Pole L; Ohuma E; Borrmann S; Ochola LI; Nzila A
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3302-7. PubMed ID: 20516285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).
    Mayxay M; Barends M; Brockman A; Jaidee A; Nair S; Sudimack D; Pongvongsa T; Phompida S; Phetsouvanh R; Anderson T; White NJ; Newton PN
    Am J Trop Med Hyg; 2007 Feb; 76(2):245-50. PubMed ID: 17297031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.
    Wilson CM; Volkman SK; Thaithong S; Martin RK; Kyle DE; Milhous WK; Wirth DF
    Mol Biochem Parasitol; 1993 Jan; 57(1):151-60. PubMed ID: 8426608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.